Evolus EOLS
NASDAQ EOLS
$7.30 -0.07 (-0.95%)
As of: Oct 21, 2026 · 11:41 AM EDT

Evolus (EOLS) Shares Repurchased (2018)

Updated

Analysis

Evolus (EOLS) Shares Repurchased (2018) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Repurchased (Qtr)
1 Eli Lilly 1,130.22 Bn 1,098.81 Bn 19.71 Bn 1.60 Bn
2 Johnson & Johnson 613.62 Bn 532.15 Bn 17.26 Bn 221.00 Mn
3 AbbVie 501.46 Bn 474.57 Bn 12.70 Bn 9.00 Mn
4 Merck 366.84 Bn 321.22 Bn 12.21 Bn 757.00 Mn
5 Novartis Ag 297.85 Bn 261.84 Bn 11.24 Bn 1.20 Bn
6 Astrazeneca 261.66 Bn 235.34 Bn 12.86 Bn -
7 Amgen 235.39 Bn 190.79 Bn 7.24 Bn -
8 Gilead Sciences 190.66 Bn 164.86 Bn 6.22 Bn 355.00 Mn
9 Pfizer 169.57 Bn 116.22 Bn 10.94 Bn -
10 Evolus 481.94 Mn 289.63 Mn 57.18 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2018 686,000.00
API Access

Evolus Shares Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=shares-repurchased&ticker=EOLS&period=max&api_key=YOUR_API_KEY